The effect of abobotulinum toxin A in the prophylactic treatment of refractory migraine (original) (raw)
Research Submissions OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program
Stephen Silberstein
2010
View PDFchevron_right
Botulinum Toxin?A Treatment for Migraine? A Systematic Review
Vinod Kumar Gupta
Pain Medicine, 2006
View PDFchevron_right
Sustained Efficacy, Safety and High Adherence Rate of Onabotulinum Toxin Type A in Chronic Migraine Patients: A Multicentric Prospective Real-Life Study
Angela Verzina
Toxins
View PDFchevron_right
PREEMPT 2 Chronic Migraine Study Group. Onabotulinum toxin A for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia
Catherine Turkel
Cephalalgia
View PDFchevron_right
Botulinum Toxin Type A in the Treatment of Chronic Migraine Without Medication Overuse
Seymour Diamond
Headache: The Journal of Head and Face Pain, 2007
View PDFchevron_right
Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study
Richard Stark
The Journal of Headache and Pain, 2018
View PDFchevron_right
PREEMPT 1 Chronic Migraine Study Group. Onabotulinum toxin A for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia
Catherine Turkel
Cephalalgia
View PDFchevron_right
OnabotulinumtoxinA: Preventive Treatment for Chronic Migraine
Jong-ling Fuh
Current Pain and Headache Reports, 2011
View PDFchevron_right
Botulinum Toxin Type A as a Migraine Preventive Treatment
Joel Saper
Headache: The Journal of Head and Face Pain, 2000
View PDFchevron_right
Long-term treatment of chronic migraine with OnabotulinumtoxinA: efficacy, quality of life and tolerability in a real-life setting
Dirk Dressler
Journal of Neural Transmission, 2016
View PDFchevron_right
A Series of Three Sequential, Randomized, Controlled Studies of Repeated Treatments With Botulinum Toxin Type A for Migraine Prophylaxis
Arthur Elkind
The Journal of Pain, 2006
View PDFchevron_right
Treatment of Chronic Migraine with OnabotulinumtoxinA: Mode of Action, Efficacy and Safety
János Tajti
Toxins, 2015
View PDFchevron_right
An open-label prospective study of the real-life use of onabotulinumtoxinA for the treatment of chronic migraine: the REPOSE study
Charly Gaul
The Journal of Headache and Pain, 2019
View PDFchevron_right
Onabotulinumtoxin-A treatment in Greek patients with chronic migraine
Emmanouil Dermitzakis
The Journal of Headache and Pain, 2016
View PDFchevron_right
Safety of Onabotulinumtoxin A in Chronic Migraine: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
assunta tarsitano
Toxins
View PDFchevron_right
Further Evidence that Onabotulinum Toxin is a Viable Treatment Option for Pediatric Chronic Migraine Patients
sameer ali
Cureus, 2019
View PDFchevron_right
Clinical treatment of chronic and episodic migraine with onabotulinumtoxinA in a real-world setting
Juan Gómez-esteban
Drugs & Therapy Perspectives, 2018
View PDFchevron_right
Onabotulinumtoxin A for the management of chronic migraine in current clinical practice: results of a survey of sixty-three Italian headache centers
Paola Sarchielli
The journal of headache and pain, 2017
View PDFchevron_right
Monocentric Prospective Study into the Sustained Effect of Incobotulinumtoxin A (XEOMIN®) Botulinum Toxin in Chronic Refractory Migraine
marie de verdal
Toxins, 2018
View PDFchevron_right
Sustained onabotulinumtoxinA therapeutic benefits in patients with chronic migraine over 3 years of treatment
Konstantinos Spingos
The journal of headache and pain, 2018
View PDFchevron_right
Method of Injection of OnabotulinumtoxinA for Chronic Migraine: A Safe, Well-Tolerated, and Effective Treatment Paradigm Based on the PREEMPT Clinical Program
Catherine Turkel
Headache: The Journal of Head and Face Pain, 2010
View PDFchevron_right
Botulinum toxin therapy of migraine and tension-type headache: comparing different botulinum toxin preparations
Juan Carlos Martínez Castrillo
European Journal of Neurology, 2006
View PDFchevron_right
Efficacy of Botulinum Toxin Type A for the Prophylaxis of Episodic Migraine Headaches: A Meta-analysis of Randomized, Double-Blind, Placebo-Controlled Trials
Adam Shuhendler
Pharmacotherapy, 2009
View PDFchevron_right
Botulinum Toxin Type A in Prophylactic Treatment of Migraine
Stephen Silberstein
American Journal of Therapeutics, 2006
View PDFchevron_right
Efficacy, safety, and predictors of response to botulinum toxin type A in refractory chronic migraine: A retrospective study
Jong-ling Fuh
Journal of the Chinese Medical Association, 2014
View PDFchevron_right
OnabotulinumtoxinA in chronic migraine: predictors of response. A prospective multicentre descriptive study
Mariano Huerta
European Journal of Neurology, 2017
View PDFchevron_right
Importance of botulinum toxin for prevention of migraine
Frederick Freitag
Expert Review of Neurotherapeutics, 2010
View PDFchevron_right
Onabotulinumtoxin A (ONA-BoNT/A) in the treatment of chronic migraine
Adam Stępień
Neurologia i Neurochirurgia Polska, 2021
View PDFchevron_right
Pooled analysis of the safety and tolerability of onabotulinumtoxinA in the treatment of chronic migraine
Mitchell Brin
European Journal of Neurology, 2014
View PDFchevron_right
Utilization and safety of onabotulinumtoxinA for the prophylactic treatment of chronic migraine from an observational study in Europe
Ingela Remahl
Cephalalgia
View PDFchevron_right